04:28

Sedatives Effects on Cognition & Fatigue in Different Indications | Sleep Related Clinical Trials

03:07

Transforming Memory Tests: Lila App & the International Shopping List Test

02:46

Rater Performance Central Monitoring (RPCM) Programs in Early Symptomatic Alzheimer Disease Trials

09:07

Evidence that Amyloid Accumulation precedes ACh Neuronal Loss | ADPD Symposium Summary #Alzheimers

01:45

Reduce rater burden & increase efficiencies in Rare Disease trials | Rater Academy model explained

03:43

Schizophrenia Trials: Placebo Response vs. Practice Effects | Cogstate Digital Tests | ISCTM Poster

02:01

Reducing placebo response in Rare Disease clinical trials

01:49

Using Indication Specific Outcome Measures in Rare Disease Clinical Trials | Rett Syndrome Approval

02:03

Relationships between Alzheimers Biomarkers & Cogstate Cognitive Tests

07:57

Sensitivity of the Cogstate Brief Battery (CBB) to Mild Cognitive Impairment and Alzheimer’s Disease

03:35

Using Cogstate Digital Tests to Identify Cognitive Impairment in Alzheimer’s Disease Clinical Trials

02:17

Self-Administered Smartphone-based & Memory Assessment | AAIC 2023 Poster Data on Lila

02:24

Bring-Your-Own-Device Trial Feasibility with Cogstate Brief Battery (CBB) | AAIC 2023 Poster

07:23

Remote Preclinical Alzheimer’s Cognitive Composite (PACC) | Reliable & Valid for Clinical Trials

01:46

CDR-SB: Improved Sensitivity to Treatment Efficacy in Future Alzheimer's Disease Clinical Trials

06:51

Enhance Clinical Trial Data Quality & Reduce Burden | Central Rating Explained

01:53

Case Study: Measuring Neurocognitive Effects of Oncology Treatments in Pediatrics

02:01

Case Study: Selecting the Appropriate Patients for Global Alzheimer’s Disease Programs

06:45

Safety Monitoring System for Real Time Detection of CNS Adverse Events in Alzheimer's Disease Trials

05:20

Computer vs Smartphone-Administered Versions of the Cogstate Brief Battery | ADPD 2023 Poster

25:36

FY23 Half Year Results | Cogstate Investor Webcast

06:05

Neuroscience Consulting Opportunities Supporting Clinical Research | Cogstate LEADs

01:15

Case Study | Demonstrating Cognitive Safety of NMDA Modulator Antidepressant Medications

04:49

Remote Assessments in Alzheimer's Disease | Remote vs In-person data from PACC & CDR-SB | CTAD

03:51

Rater Perspectives on Applied Training of Cognitive Clinical Outcome Assessments (COAs) | AAIC 2022

49:19

Cogstate Investor Webcast | Full Year 2022 Results

01:22

Case Study: CAR T-Cell Therapy | Cognitive Safety | Cogstate

03:13

User Led Design of a Self-Administered Smartphone-based Learning & Memory Assessment | AAIC 2022

03:08

Detection of Mild Cognitive Impairment (MCI) | In-Clinic & Remote Cognitive Assessments | AAIC 2022

05:09

Dementia with Lewy Bodies | Disease-Specific Global Clinical Rating Scales | ADPD 2022 Poster

08:01

Dementia with Lewy Bodies | Composite Cognitive Outcome Measure | ADPD

54:18

FY22 Half Year Results | Cogstate Investor Webcast

08:03

Increase Rater Training Efficiency for Rare Disease Clinical Trials | NORD 2021 Poster

08:18

CTAD Recap | Trends in AD Drug Development

13:11

Parkinson's Disease Clinical Trial Services and Resources

10:41

Validity and Sensitivity of the Cogstate Brief Battery | ADNI3 | AD/PD 2021

37:13

FY21 Half Year Results | Cogstate Investor Webcast

05:26

Central Rating | Basics and Benefits for Rare Disease Clinical Trials

28:59

Designing Computerized Test Batteries for Clinical Trials

15:56

Cognitive Assessments as Efficacy Outcome Measures

19:12

Cognitive Assessments as Safety Outcome Measures

15:16

Using Cognitive Assessments to Guide Decision Making - Part Two

26:54

Using Cognitive Assessments to Guide Decision Making - Part One

09:04

Cogstate and Eisai Global Partnership | Early Identification of Alzheimer's Disease

38:04

June Quarter FY20 Business Update | Cogstate

17:01

First Half FY20 Business Update | Cogstate

43:48

FY20 Financial Results | Cogstate Investor Webcast

02:58

Initial Exploration of a Brain Age Score | Computerized Cognitive Assessments

11:46

Remote Cognitive Assessment Considerations and Capabilities for Clinical Trials | Cogstate

32:16

C3 Computerized Cognitive Battery | Results from A4 Study Baseline Data

03:14

Clinical Trials for Cognitive Impairment Associated with Schizophrenia - Cogstate Battery

02:57

Clinical Outcome Assessments for Clinical Trials in Rare Tauopathies

04:55

Measuring Cognition in Pediatric Oncology Clinical Trials

02:10

Computerized Cognitive Assessments: Cogstate Brief Battery

07:29

Cognitive Change Associated with Anesthesia and Surgery

04:29

Measuring Cognitive Function: Tools for Healthcare Professionals (Cognigram)

03:25

Computerized Cognitive Testing: Advantages for Clinical Trials

06:08

Rater Training and Subject Eligibility Review in Clinical Trials

11:19

FDA Draft Guidance: Rare Disease Clinical Trials

03:35

Cognitive Assessment for Clinical Trials: International Shopping List Test (ISLT)